EyePoint Pharmaceuticals Inc (EYPT)
Aktien-Chart
Earnings
Value bought
Letzte 90 Tage
Value sold
Letzte 90 Tage
Net insiders buying
Letzte 90 Tage
Trades (buy and sell)
Letzte 90 Tage
| Datum der Benachrichtigung | Datum der Transaktion | K/V Art der Transaktion | Insider und/oder position |
Anz. der Aktien Kurs Wert |
Anzahl der Aktien | Kurs | Wert | Details |
|---|---|---|---|---|---|---|---|---|
| 2024-08-21 | 2024-08-21 | K Kauf | Nicht geschäftsführender Verwaltungsratsmitglied |
5.000
+61.3%
7,9539.750 USD |
5.000 +61.3% | 7,95 | 39.750 USD | |
| 2024-08-21 | 2024-08-20 | K Kauf | Nicht geschäftsführender Verwaltungsratsmitglied |
2.567
+34.7%
7,7919.997 USD |
2.567 +34.7% | 7,79 | 19.997 USD | |
| 2024-08-21 | 2024-08-19 | K Kauf | Nicht geschäftsführender Verwaltungsratsmitglied |
12.500
+312.5%
7,9899.750 USD |
12.500 +312.5% | 7,98 | 99.750 USD | |
| 2024-08-20 | 2024-08-16 | K Kauf | Nicht geschäftsführender Verwaltungsratsmitglied |
3.173
+3.4%
7,8825.003 USD |
3.173 +3.4% | 7,88 | 25.003 USD | |
| 2024-07-16 | 2024-07-12 | V Verkauf | Nicht geschäftsführender Verwaltungsratsmitglied |
11.625
-86.3%
10,06116.995 USD |
11.625 -86.3% | 10,06 | 116.995 USD | |
| 2024-06-04 | 2024-06-03 | V Verkauf | Nicht geschäftsführender Verwaltungsratsmitglied |
11.625
-75.9%
10,30119.705 USD |
11.625 -75.9% | 10,30 | 119.705 USD | |
| 2024-05-16 | 2024-05-14 | V Verkauf | Nicht geschäftsführender Verwaltungsratsmitglied |
11.625
-67.7%
12,65147.045 USD |
11.625 -67.7% | 12,65 | 147.045 USD | |
| 2024-05-08 | 2024-05-06 | K Kauf |
Cormorant Asset Management, LP Large shareholder |
207.153
+2.6%
12,362.560.411 USD |
207.153 +2.6% | 12,36 | 2.560.411 USD | |
| 2024-05-08 | 2024-05-06 | K Kauf |
Cormorant Asset Management, LP Large shareholder |
642.847
+8.6%
11,707.521.310 USD |
642.847 +8.6% | 11,70 | 7.521.310 USD | |
| 2024-04-22 | 2024-04-18 | K Kauf |
Cormorant Asset Management, LP Large shareholder |
186.521
+2.6%
18,903.525.247 USD |
186.521 +2.6% | 18,90 | 3.525.247 USD | |
| 2024-04-22 | 2024-04-18 | K Kauf |
Cormorant Asset Management, LP Large shareholder |
395.244
+5.7%
17,626.964.199 USD |
395.244 +5.7% | 17,62 | 6.964.199 USD | |
| 2024-02-05 | 2024-02-02 | V Verkauf |
SVP & Chief Commercial Officer Führungsperson |
209
-0.5%
28,495.954 USD |
209 -0.5% | 28,49 | 5.954 USD | |
| 2024-01-30 | 2024-01-26 | V Verkauf |
Chief Medical Officer Führungsperson |
33.665
-48.0%
25,77867.672 USD |
33.665 -48.0% | 25,77 | 867.672 USD | |
| 2024-01-30 | 2024-01-26 | V Verkauf |
Chief Medical Officer Führungsperson |
15.609
-18.2%
25,41396.572 USD |
15.609 -18.2% | 25,41 | 396.572 USD | |
| 2024-01-30 | 2024-01-26 | V Verkauf |
Chief Medical Officer Führungsperson |
51
-0.1%
25,411.296 USD |
51 -0.1% | 25,41 | 1.296 USD | |
| 2024-01-29 | 2024-01-26 | V Verkauf |
SVP & Chief Commercial Officer Führungsperson |
9.604
-20.2%
25,27242.717 USD |
9.604 -20.2% | 25,27 | 242.717 USD | |
| 2024-01-29 | 2024-01-26 | V Verkauf |
SVP & Chief Commercial Officer Führungsperson |
16.413
-25.7%
25,45417.653 USD |
16.413 -25.7% | 25,45 | 417.653 USD | |
| 2024-01-29 | 2024-01-25 | V Verkauf |
Chief Medical Officer Führungsperson |
300
-0.8%
25,007.500 USD |
300 -0.8% | 25,00 | 7.500 USD | |
| 2024-01-29 | 2024-01-25 | V Verkauf |
Chief Medical Officer Führungsperson |
300
-0.8%
25,007.500 USD |
300 -0.8% | 25,00 | 7.500 USD | |
| 2024-01-26 | 2024-01-25 | V Verkauf |
SVP & Chief Commercial Officer Führungsperson |
300
-0.8%
25,007.500 USD |
300 -0.8% | 25,00 | 7.500 USD | |
| 2024-01-26 | 2024-01-25 | V Verkauf |
SVP & Chief Commercial Officer Führungsperson |
300
-0.8%
25,007.500 USD |
300 -0.8% | 25,00 | 7.500 USD | |
| 2024-01-26 | 2024-01-24 | V Verkauf |
SVP & Chief Commercial Officer Führungsperson |
5.600
-12.9%
25,01140.068 USD |
5.600 -12.9% | 25,01 | 140.068 USD | |
| 2024-01-26 | 2024-01-24 | V Verkauf |
SVP & Chief Commercial Officer Führungsperson |
5.700
-11.6%
25,01142.554 USD |
5.700 -11.6% | 25,01 | 142.554 USD | |
| 2024-01-25 | 2024-01-24 | V Verkauf |
Chief Medical Officer Führungsperson |
5.651
-13.4%
25,02141.363 USD |
5.651 -13.4% | 25,02 | 141.363 USD | |
| 2024-01-25 | 2024-01-24 | V Verkauf |
Chief Medical Officer Führungsperson |
5.600
-11.7%
25,01140.052 USD |
5.600 -11.7% | 25,01 | 140.052 USD | |
| 2024-01-25 | 2024-01-24 | V Verkauf |
Executive Vice Chair Geschäftsführender Verwaltungsratsmitglied |
29.956
-18.1%
24,98748.250 USD |
29.956 -18.1% | 24,98 | 748.250 USD | |
| 2024-01-25 | 2024-01-23 | V Verkauf |
Chief Medical Officer Führungsperson |
3.096
-7.8%
25,0077.400 USD |
3.096 -7.8% | 25,00 | 77.400 USD | |
| 2024-01-25 | 2024-01-23 | V Verkauf |
Chief Medical Officer Führungsperson |
2.039
-4.9%
25,0050.975 USD |
2.039 -4.9% | 25,00 | 50.975 USD | |
| 2024-01-25 | 2024-01-23 | V Verkauf |
Executive Vice Chair Geschäftsführender Verwaltungsratsmitglied |
5.044
-3.0%
24,97125.950 USD |
5.044 -3.0% | 24,97 | 125.950 USD | |
| 2024-01-24 | 2024-01-23 | V Verkauf |
SVP & Chief Commercial Officer Führungsperson |
500
-1.3%
25,0012.500 USD |
500 -1.3% | 25,00 | 12.500 USD | |
| 2024-01-24 | 2024-01-23 | V Verkauf |
SVP & Chief Commercial Officer Führungsperson |
400
-1.0%
25,0010.000 USD |
400 -1.0% | 25,00 | 10.000 USD | |
| 2024-01-24 | 2024-01-22 | V Verkauf |
SVP & Chief Commercial Officer Führungsperson |
28.750
-43.1%
22,69652.254 USD |
28.750 -43.1% | 22,69 | 652.254 USD | |
| 2024-01-24 | 2024-01-22 | V Verkauf |
SVP & Chief Commercial Officer Führungsperson |
5.416
-7.5%
22,24120.437 USD |
5.416 -7.5% | 22,24 | 120.437 USD | |
| 2024-01-16 | 2024-01-11 | V Verkauf | Nicht geschäftsführender Verwaltungsratsmitglied |
1.910.500
-95.0%
19,4537.159.225 USD |
1.910.500 -95.0% | 19,45 | 37.159.225 USD | |
| 2024-01-16 | 2024-01-11 | V Verkauf | Nicht geschäftsführender Verwaltungsratsmitglied |
1.910.500
-95.0%
19,4537.159.225 USD |
1.910.500 -95.0% | 19,45 | 37.159.225 USD | |
| 2024-01-11 | 2024-01-11 | K Kauf |
Cormorant Asset Management, LP Large shareholder |
750.000
+12.2%
19,7514.812.500 USD |
750.000 +12.2% | 19,75 | 14.812.500 USD | |
| 2024-01-11 | 2024-01-09 | K Kauf |
Cormorant Asset Management, LP Large shareholder |
105.000
+1.7%
21,322.238.600 USD |
105.000 +1.7% | 21,32 | 2.238.600 USD | |
| 2024-01-10 | 2024-01-08 | V Verkauf |
Chief Medical Officer Führungsperson |
22.913
-38.6%
21,13484.124 USD |
22.913 -38.6% | 21,13 | 484.124 USD | |
| 2023-12-15 | 2023-12-13 | V Verkauf |
Chief Medical Officer Führungsperson |
1.458
-5.4%
20,0029.160 USD |
1.458 -5.4% | 20,00 | 29.160 USD | |
| 2023-12-12 | 2023-12-08 | K Kauf |
Cormorant Asset Management, LP Large shareholder |
588.235
+10.8%
17,009.999.995 USD |
588.235 +10.8% | 17,00 | 9.999.995 USD | |
| 2023-12-07 | 2023-12-06 | V Verkauf | Nicht geschäftsführender Verwaltungsratsmitglied |
266.242
-11.7%
18,414.901.515 USD |
266.242 -11.7% | 18,41 | 4.901.515 USD | |
| 2023-12-07 | 2023-12-06 | V Verkauf | Nicht geschäftsführender Verwaltungsratsmitglied |
266.242
-11.7%
18,414.901.515 USD |
266.242 -11.7% | 18,41 | 4.901.515 USD | |
| 2023-12-07 | 2023-12-05 | V Verkauf | Nicht geschäftsführender Verwaltungsratsmitglied |
733.758
-24.4%
19,9114.609.122 USD |
733.758 -24.4% | 19,91 | 14.609.122 USD | |
| 2023-12-07 | 2023-12-05 | V Verkauf | Nicht geschäftsführender Verwaltungsratsmitglied |
733.758
-24.4%
19,9114.609.122 USD |
733.758 -24.4% | 19,91 | 14.609.122 USD | |
| 2023-12-06 | 2023-12-04 | V Verkauf |
Executive Vice Chair Geschäftsführender Verwaltungsratsmitglied |
20.000
-10.5%
20,76415.200 USD |
20.000 -10.5% | 20,76 | 415.200 USD | |
| 2023-12-06 | 2023-12-04 | K Kauf |
Cormorant Asset Management, LP Large shareholder |
8.260
+0.2%
34,49284.887 USD |
8.260 +0.2% | 34,49 | 284.887 USD | |
| 2023-12-06 | 2023-12-04 | K Kauf |
Cormorant Asset Management, LP Large shareholder |
19.866
+0.4%
33,75670.478 USD |
19.866 +0.4% | 33,75 | 670.478 USD | |
| 2023-12-06 | 2023-12-04 | K Kauf |
Cormorant Asset Management, LP Large shareholder |
41.824
+0.8%
33,081.383.538 USD |
41.824 +0.8% | 33,08 | 1.383.538 USD | |
| 2023-12-06 | 2023-12-04 | K Kauf |
Cormorant Asset Management, LP Large shareholder |
86.713
+1.6%
31,832.760.075 USD |
86.713 +1.6% | 31,83 | 2.760.075 USD | |
| 2023-12-06 | 2023-12-04 | K Kauf |
Cormorant Asset Management, LP Large shareholder |
15.582
+0.3%
30,74478.991 USD |
15.582 +0.3% | 30,74 | 478.991 USD | |
| 2023-12-06 | 2023-12-04 | K Kauf |
Cormorant Asset Management, LP Large shareholder |
18.601
+0.4%
29,91556.356 USD |
18.601 +0.4% | 29,91 | 556.356 USD | |
| 2023-12-06 | 2023-12-04 | K Kauf |
Cormorant Asset Management, LP Large shareholder |
8.168
+0.2%
28,78235.075 USD |
8.168 +0.2% | 28,78 | 235.075 USD | |
| 2023-12-06 | 2023-12-04 | K Kauf |
Cormorant Asset Management, LP Large shareholder |
27.425
+0.5%
27,87764.335 USD |
27.425 +0.5% | 27,87 | 764.335 USD | |
| 2023-12-06 | 2023-12-04 | K Kauf |
Cormorant Asset Management, LP Large shareholder |
53.109
+1.0%
26,731.419.604 USD |
53.109 +1.0% | 26,73 | 1.419.604 USD | |
| 2023-12-06 | 2023-12-04 | K Kauf |
Cormorant Asset Management, LP Large shareholder |
65.086
+1.3%
25,881.684.426 USD |
65.086 +1.3% | 25,88 | 1.684.426 USD | |
| 2023-12-06 | 2023-12-04 | K Kauf |
Cormorant Asset Management, LP Large shareholder |
39.899
+0.8%
24,87992.288 USD |
39.899 +0.8% | 24,87 | 992.288 USD | |
| 2023-12-06 | 2023-12-04 | K Kauf |
Cormorant Asset Management, LP Large shareholder |
37.081
+0.7%
24,01890.315 USD |
37.081 +0.7% | 24,01 | 890.315 USD | |
| 2023-12-06 | 2023-12-04 | K Kauf |
Cormorant Asset Management, LP Large shareholder |
28.090
+0.6%
22,80640.452 USD |
28.090 +0.6% | 22,80 | 640.452 USD | |
| 2023-12-06 | 2023-12-04 | K Kauf |
Cormorant Asset Management, LP Large shareholder |
79.805
+1.6%
21,871.745.335 USD |
79.805 +1.6% | 21,87 | 1.745.335 USD | |
| 2023-12-06 | 2023-12-04 | K Kauf |
Cormorant Asset Management, LP Large shareholder |
122.625
+2.6%
20,622.528.528 USD |
122.625 +2.6% | 20,62 | 2.528.528 USD | |
| 2023-12-06 | 2023-12-04 | K Kauf |
Cormorant Asset Management, LP Large shareholder |
945.664
+24.5%
19,8818.799.800 USD |
945.664 +24.5% | 19,88 | 18.799.800 USD | |
| 2023-12-06 | 2023-12-04 | K Kauf |
Cormorant Asset Management, LP Large shareholder |
321.259
+9.1%
18,806.039.669 USD |
321.259 +9.1% | 18,80 | 6.039.669 USD | |
| 2023-12-06 | 2023-12-04 | V Verkauf |
Chief Corp Dev.&Strat. Officer Führungsperson |
45.000
-89.4%
22,00990.000 USD |
45.000 -89.4% | 22,00 | 990.000 USD | |
| 2023-12-06 | 2023-12-04 | V Verkauf |
Chief Medical Officer Führungsperson |
30.625
-54.4%
22,00673.750 USD |
30.625 -54.4% | 22,00 | 673.750 USD | |
| 2023-09-06 | 2023-09-01 | V Verkauf |
See footnotes 1 and 3 Large shareholder |
20.000
-0.6%
9,90197.982 USD |
20.000 -0.6% | 9,90 | 197.982 USD | |
| 2023-09-01 | 2023-08-31 | V Verkauf |
See footnotes 1 and 6 Large shareholder |
7.017
-0.2%
11,0277.337 USD |
7.017 -0.2% | 11,02 | 77.337 USD | |
| 2023-09-01 | 2023-08-31 | V Verkauf |
See footnotes 1 and 6 Large shareholder |
71.478
-2.0%
10,17726.724 USD |
71.478 -2.0% | 10,17 | 726.724 USD | |
| 2023-09-01 | 2023-08-30 | V Verkauf |
See footnotes 1 and 6 Large shareholder |
327
-0.0%
11,363.715 USD |
327 -0.0% | 11,36 | 3.715 USD | |
| 2023-09-01 | 2023-08-30 | V Verkauf |
See footnotes 1 and 6 Large shareholder |
60.649
-1.7%
10,92662.433 USD |
60.649 -1.7% | 10,92 | 662.433 USD | |
| 2023-08-30 | 2023-08-29 | V Verkauf |
See footnotes 1 and 4 Large shareholder |
565
-0.0%
11,566.531 USD |
565 -0.0% | 11,56 | 6.531 USD | |
| 2023-08-30 | 2023-08-29 | V Verkauf |
See footnotes 1 and 4 Large shareholder |
87.289
-2.3%
10,74937.693 USD |
87.289 -2.3% | 10,74 | 937.693 USD | |
| 2023-08-30 | 2023-08-28 | V Verkauf |
See footnotes 1 and 4 Large shareholder |
60.858
-1.6%
11,71712.653 USD |
60.858 -1.6% | 11,71 | 712.653 USD | |
| 2023-08-28 | 2023-08-25 | V Verkauf |
See footnotes 1 and 2 Large shareholder |
54.656
-1.4%
11,19611.349 USD |
54.656 -1.4% | 11,19 | 611.349 USD | |
| 2023-08-28 | 2023-08-25 | V Verkauf |
See footnotes 1 and 2 Large shareholder |
30.000
-0.8%
10,67320.130 USD |
30.000 -0.8% | 10,67 | 320.130 USD | |
| 2023-08-28 | 2023-08-24 | V Verkauf |
See footnotes 1 and 2 Large shareholder |
139.280
-3.5%
14,622.036.093 USD |
139.280 -3.5% | 14,62 | 2.036.093 USD |